Breaking News Instant updates and real-time market news.

AIG

AIG

$59.95

0.05 (0.08%)

06:49
10/07/16
10/07
06:49
10/07/16
06:49

AIG initiated with a Neutral at Credit Suisse

Credit Suisse analyst John Nadel initiated AIG with a Neutral and a $60 price target.

  • 04

    Nov

  • 18

    Nov

AIG AIG
$59.95

0.05 (0.08%)

06/30/16
06/30/16
UPGRADE
Target $60

Overweight
AIG upgraded to Overweight on valuation at Atlantic Equities
As previously reported, Atlantic Equities upgraded AIG to Overweight from Equal Weight. Analyst John Heagerty said the selloff in shares is overdone given the firm's $25B capital management program remains largely intact and said the planned $22B+ of buybacks over the next two years should prove to be extremely value enhancing. Given management's renewed focus on ROE improvement, Heagerty views current valuation as an excellent buying opportunity.
07/06/16
EVER
07/06/16
INITIATION
Target $62
EVER
Buy
AIG initiated with a Buy at Evercore ISI
Evercore ISI analyst Thomas Gallagher started AIG with a Buy rating and $62 price target.
08/08/16
GSCO
08/08/16
UPGRADE
Target $68
GSCO
Conviction Buy
AIG upgraded to Conviction Buy from Buy at Goldman
Goldman Sachs analyst Michael Nannizzi upgraded AIG to Conviction Buy saying the risk/reward is "increasingly attractive" following the company's "strong" Q2 results. The analyst expects margin expansion as the year progresses and has as $68 price target for the shares.
08/08/16
08/08/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AIG (AIG) upgraded to Conviction Buy from Buy at Goldman with analyst Michael Nannizzi saying the risk/reward is "increasingly attractive" following the company's "strong" second quarter results. 2. 58.com (WUBA) upgraded to Buy from Sell at CLSA with analyst Man Ho Lam saying shares are down 21% year-to-date and reflect margin concerns and the unlocking of restricted shares. 3. Reynolds American (RAI) upgraded to Outperform from Underperform at CLSA with analyst Michael Lavery saying valuation is compelling relative to Altria (MO) and expects strong portfolio, share momentum, and multiple levers to drive earnings growth. 4. Merck (MRK) upgraded to Outperform from Neutral at Credit Suisse with analyst Vamil Divan upgrading the stock to Outperform and raised its price target to $73 following news that Bristol-Meyers' (BMY) CheckMate-026 study failed to meet its primary endpoint. 5. Monsanto (MON) upgraded to Buy from Neutral at Monness Crespi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.